However, for the Company, 2024 was both a “year of restructuring” amidst challenges and a “year of breakthroughs” with emerging potentials. Although the overall performance is experiencing short-term ...

Tonix Pharmaceuticals Holding Corp.’s TNXP share price has surged by 16.43%, which has investors questioning if this is right ...

BEIJING -- British pharmaceutical giant AstraZeneca signed a landmark $2.5-billion agreement on Friday to invest in Beijing ...

Non-communicable diseases are costing the EU billions of euros annually. Increasing investment in detection, diagnosis, and ...

Key Takeaways Telix Pharmaceuticals reported that the U.S. Food and Drug Administration approved its agent indicated for ...